Latest news
Cullinan Therapeutics (NASDAQ:CGEM) Issues Quarterly Earnings Results - MarketBeatMarketBeat · Sat, 08 Aug 2026 03:25:30 GMTRenaissance Technologies LLC Sells 307,595 Shares of Cullinan Therapeutics, Inc. $CGEM - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:44:45 GMTCullinan Therapeutics (NASDAQ:CGEM) Price Target Raised to $39.00 - MarketBeatMarketBeat · Wed, 29 Jul 2026 07:00:00 GMT